References

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

10.1016/s1470-2045(15)70076-8 · 2015 · External reference

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

10.1056/nejmoa1606774 · 2016 · External reference

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.

10.1016/s0140-6736(18)31999-8 · 2019 · External reference

Cancer immunotherapy using checkpoint blockade

10.1126/science.aar4060 · 2018 · External reference

Immune-related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity

10.1111/imr.13247 · 2023 · External reference

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.

10.1136/jitc-2021-003956 · 2022 · External reference

The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors.

10.1186/s40425-019-0768-9 · 2019 · External reference

PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer.

10.3390/cancers13030558 · 2021 · External reference

Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta-analysis.

10.1002/hed.26997 · 2022 · External reference

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors.

10.1038/s41467-021-20935-9 · 2021 · External reference

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations.

10.1007/s10585-024-10266-6 · 2024 · External reference

What You Need to Know Before Implementing a Clinical Research Data Warehouse: Comparative Review of Integrated Data Repositories in Health Care Institutions.

10.2196/17687 · 2020 · External reference

Accessing and utilizing clinical and genomic data from an electronic health record data warehouse.

2023 · External reference

Extracting research-quality phenotypes from electronic health records to support precision medicine

10.1186/s13073-015-0166-y · 2015 · External reference

Understanding diagnostic tests 3: Receiver operating characteristic curves

10.1111/j.1651-2227.2006.00178.x · 2007 · External reference

User’s guide to correlation coefficients

10.1016/j.tjem.2018.08.001 · 2018 · External reference

A Clinical Data Warehouse Analysis of Risk Factors for Inpatient Falls in a Tertiary Hospital: A Case-Control Study.

10.1097/pts.0000000000001163 · 2023 · External reference

Maternal, Fetal and Neonatal Outcomes Related to Recreational Cannabis Use during Pregnancy: Analysis of a Real-World Clinical Data Warehouse between 2010 and 2019

2023 · External reference

Secondary Use and Analysis of Big Data Collected for Patient Care.

10.15265/iy-2017-008 · 2017 · External reference

Association between red blood cell distribution width and outcomes at six months in patients with acute coronary syndromes

2009 · External reference

Relation between red cell distribution width and clinical outcomes after acute myocardial infarction

10.1016/j.amjcard.2009.09.027 · 2010 · External reference

Prognostic value of red blood cell distribution width for patients with heart failure: a systematic review and meta-analysis of cohort studies

10.1371/journal.pone.0104861 · 2014 · External reference

Red cell distribution width and neurological scoring systems in acute stroke patients

10.2147/ndt.s81525 · 2015 · External reference

Prognostic significance of increased preoperative red cell distribution width (RDW) and changes in RDW for colorectal cancer.

2023 · External reference

Does red blood cell distribution width predict prognosis in metastatic renal cell carcinoma patients using first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy?

10.4103/jcrt.jcrt_898_22 · 2023 · External reference

Determinants of red cell distribution width (RDW) in cardiorenal patients: RDW is not related to erythropoietin resistance.

10.1016/j.cardfail.2011.04.009 · 2011 · External reference

Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure

10.1016/j.cardfail.2009.11.003 · 2010 · External reference

Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers

10.1016/j.bcp.2015.06.009 · 2015 · External reference

Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity

10.1111/cas.13433 · 2018 · External reference

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

10.1136/gutjnl-2016-311585 · 2018 · External reference

Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer

10.1371/journal.pone.0080240 · 2013 · External reference

Clinical Significance of Pretreatment Red Blood Cell Distribution Width as a Predictive Marker for Postoperative Morbidity After Esophagectomy for Esophageal Cancer: A Retrospective Study

10.1245/s10434-021-10719-2 · 2022 · External reference

Prognostic Effect of the Controlling Nutritional Status Score in Patients With Esophageal Cancer Treated With Immune Checkpoint Inhibitor

10.1097/cji.0000000000000438 · 2022 · External reference

Association between body mass index and survival outcomes for cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

10.1186/s12967-020-02404-x · 2020 · External reference

Prognostic Nutritional Index Predicts Response and Prognosis in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

10.3389/fnut.2022.823087 · 2022 · External reference